CA2068366A1 — Microcapsule composition and process
Assigned to Mayne Pharma International Pty Ltd · Expires 1992-11-11 · 34y expired
What this patent protects
ABSTRACT OF THE DISCLOSURE A taste-masked free-flowing powder includes microcapsules having a particle size of approximately 300 µm or less. Each microcapsule includes an effective amount of a core element including at least one pharmaceutically active ingredient. A substa…
USPTO Abstract
ABSTRACT OF THE DISCLOSURE A taste-masked free-flowing powder includes microcapsules having a particle size of approximately 300 µm or less. Each microcapsule includes an effective amount of a core element including at least one pharmaceutically active ingredient. A substantially smooth and continuous microcapsule coating on the core element is formed from a coating composition including a water insoluble polymer. The coated microcapsules exhibit a reduced dissolution profile.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.